7WSL
 
 | PD-1 in complex with Dostarlimab | Descriptor: | Programmed cell death protein 1, heavy chain, light chain | Authors: | Heo, Y.S. | Deposit date: | 2022-01-30 | Release date: | 2022-08-24 | Last modified: | 2024-11-06 | Method: | X-RAY DIFFRACTION (1.534 Å) | Cite: | Molecular basis of PD-1 blockade by dostarlimab, the FDA-approved antibody for cancer immunotherapy. Biochem.Biophys.Res.Commun., 599, 2022
|
|